SAB Biotherapeutics SABS
NASDAQ SABS
$3.17 -0.05 (-1.55%)
At close: Sep 30, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Other financing activities (2025 - 2026)

Updated

SAB Biotherapeutics (SABS) posted Other financing activities of $4,000 for Q2 2026, down 20.0% from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Other financing activities (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities at SAB Biotherapeutics was $18,133; for FY2025, it came in at $11,205, down 55.1% from FY2024.

  • In prior years, SAB Biotherapeutics' Other financing activities was $24,931 in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Other financing activities since Q1 2025.
  • According to Business Quant data, Other financing activities for the three prior quarters was $5,000 (Q1 2026), $4,252 (Q4 2025) and $4,881 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 SAB Biotherapeutics 264.67 Mn 264.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,000.00
Mar 31, 2026 5,000.00
Dec 31, 2025 4,252.00
Sep 30, 2025 4,881.00
Mar 31, 2025 2,000.00
API Access

SAB Biotherapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SABS&period=max&api_key=YOUR_API_KEY